Abstract:With the increasing aging of the population, the rational drug design for the treatment of Alzheimer's disease (AD) has become an important research area. Based on the multi-target design strategy, three coumarin derivatives 3a-3c were designed, synthesized and characterized by 1H NMR, 13C NMR and MS. The biological results showed that they had strong inhibition and high selectivity on acetylcholinesterase (AChE). Compound 3a had the strongest inhibitory effect on AChE (IC50 = 4.28 ± 0.22 μM). And all compounds could inhibit the self-induced and Cu2+-induced aggregation of β-amyloid (Aβ1-42), especially 3a had the best inhibitory effect on the self-aggregation of Aβ1-42 with the ratio of 64.27%. In addition, all compounds showed good antioxidant activity, which might be related to their hydroxyl groups. The compounds had good metal chelating ability, and could selectively chelate Cu2+, Al3+, Fe3+, Fe2+, and Zn2+ ions. Notably, the single crystals of 3b−Cu(II) complex [Cu2(C17H19N2O4)2Cl2]·2CH3OH were prepared and X-ray diffracted for the first time. X-ray crystallography analysis of 3b−Cu(II) complex provided a reliable structure-activity insight about the anti-oxidative and Aβ1-42 disaggregation activities. Furthermore, the results of docking study were consistent with the results of in vitro experiments. 3a-3c were predicted to have good blood brain barrier permeability and ADMET properties. Overall, 3a showed the best activity and might be a promising anti-AD agent.

Synthesis and Biological Evaluation of Deferiprone-Resveratrol Hybrids As Antioxidants, Aβ1–42 Aggregation Inhibitors and Metal-Chelating Agents for Alzheimer's Disease

Resveratrol-maltol Hybrids As Multi-Target-directed Agents for Alzheimer's Disease.

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Novel 1-phenyl-3-hydroxy-4-pyridinone derivatives as Multifunctional Agents for the therapy of Alzheimer's Disease.

Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease.

Identification of 2-subsituted benzothiazole derivatives as triple-functional agents with potential for AD therapy

Design, Synthesis, And Evaluation Of Resveratrol Derivatives As A Beta(1-42) Aggregation Inhibitors, Antioxidants, And Neuroprotective Agents

Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity

Synthesis and Evaluation of Selegiline Derivatives As Monoamine Oxidase Inhibitor, Antioxidant and Metal Chelator Against Alzheimer's Disease.

Design, Synthesis and Evaluation of a Novel Metal Chelator As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Identification of N-phenyl-3-methoxy-4-pyridinones As Orally Bioavailable H3 Receptor Antagonists and Β-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer's Disease.

Design, synthesis and evaluation of clioquinol-ebselen hybrids as multi-target-directed ligands against Alzheimer’s disease

Chromone-deferiprone hybrids as novel MAO-B inhibitors and iron chelators for the treatment of Alzheimer's disease

Multitarget-directed Benzylideneindanone Derivatives: Anti-Β-amyloid (aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties Against Alzheimer's Disease.

Design, Synthesis and Evaluation of Novel Bivalent Β-Carboline Derivatives As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Design, Synthesis and Evaluation of 4 '-Oh-flurbiprofen-chalcone Hybrids As Potential Multifunctional Agents for Alzheimer's Disease Treatment

Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease

New Multi-Target-directed Small Molecules Against Alzheimer's Disease: a Combination of Resveratrol and Clioquinol.

Synthesis and evaluation of donepezil–ferulic acid hybrids as multi-target-directed ligands against Alzheimer's disease

Synthesis and Evaluation of Clioquinol-Rolipram/roflumilast Hybrids As Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.

Novel coumarin derivatives as multifunctional anti-AD agents: Design, synthesis, X-ray crystal structure and biological evaluation